KNIGHT CAPITAL GROUP LLC - IMMUNOCELLULAR THERAPEUTICS ownership

IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 48 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q2 2013. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
KNIGHT CAPITAL GROUP LLC ownership history of IMMUNOCELLULAR THERAPEUTICS
ValueSharesWeighting
Q2 2013$31,00015,9180.00%
Other shareholders

There were no reported owners of IMMUNOCELLULAR THERAPEUTICS in Q2 2013.

NameSharesValueWeighting ↓
View complete list of IMMUNOCELLULAR THERAPEUTICS shareholders